Conference
521 Safety and efficacy of Durvalumab (D) + Tremelimumab (T) + Metronomic Oral Vinorelbine (MOV) in patients with recurrent/metastatic cervical cancer (RMCC) in the MOVIE trial
| العنوان: | 521 Safety and efficacy of Durvalumab (D) + Tremelimumab (T) + Metronomic Oral Vinorelbine (MOV) in patients with recurrent/metastatic cervical cancer (RMCC) in the MOVIE trial |
|---|---|
| المؤلفون: | Frenel, Jean-Sebastien, Mathiot, Laurent, Bocorman, Edith, Hervieu, Alice, Coquan, Elodie, Rouge, Thibault De La Motte, Saada-Bouzid, Esma, Sabatier, Renaud, Lavaud, Pernelle, Legrand, François, Cropet, Claire, Charaffe, Emmanuelle, Goncalves, Anthony |
| المصدر: | Oral Sessions ; page A9.1-A9 |
| بيانات النشر: | BMJ Publishing Group Ltd |
| سنة النشر: | 2024 |
| نوع الوثيقة: | conference object |
| اللغة: | unknown |
| DOI: | 10.1136/ijgc-2024-esgo.14 |
| DOI: | 10.1136/ijgc-2024-ESGO.14 |
| الاتاحة: | http://dx.doi.org/10.1136/ijgc-2024-esgo.14 https://syndication.highwire.org/content/doi/10.1136/ijgc-2024-ESGO.14 |
| رقم الانضمام: | edsbas.B7C7C9AC |
| قاعدة البيانات: | BASE |
| DOI: | 10.1136/ijgc-2024-esgo.14 |
|---|